公开(公告)号：US20230414865A1

公开(公告)日：2023-12-28

申请号：US18340339

申请日：2023-06-23

Applicant: INSULET CORPORATION

Inventor： Jianhong ZHAO ,  Soroush KAMRAVA ,  James CAUSEY ,  Daniel BARRETT ,  Craig BRODEUR ,  Eric DUHAMEL ,  Ann LIU ,  Ian MCLAUGHLIN

IPC: A61M5/142 ,  A61M5/158 ,  A61M5/148

CPC classification number: A61M5/14248 ,  A61M5/158 ,  A61M5/148 ,  A61M2005/14252 ,  A61M2005/1585

Abstract: A drug delivery device including a reservoir operable to contain a liquid drug, a fluid outlet including an outlet reservoir opening and an outlet fluid channel, wherein the outlet reservoir opening has a volume and is fluidly coupled to the outlet fluid channel, and an outlet filter plug operable to fill the volume of the outlet reservoir opening and collect particulate material as the liquid drug is expelled from the reservoir.

公开(公告)号：US20220062536A1

公开(公告)日：2022-03-03

申请号：US17412729

申请日：2021-08-26

Applicant: Insulet Corporation

Inventor： Jason O'CONNOR ,  Matthew ALLES ,  Robert SANZONE ,  Craig BRODEUR ,  Joseph MELO ,  Christopher WILLIAMS ,  Noel SCHAEFFER

IPC: A61M5/142

Abstract: The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal-only dosing of insulin. In a primary embodiment, the wearable drug delivery device is configured to provide automatic operation and provides audible alerts and visual status indicators to the patient. In other embodiments, the patient may have some degree of control over the operation of the device by providing tapping gestures on housing of the device. In yet another embodiment, the patient may provide input and receive status from the device via an application executing on a portable computing device in wireless communication with the wearable drug delivery device.

公开(公告)号：US20250065039A1

公开(公告)日：2025-02-27

申请号：US18885257

申请日：2024-09-13

Applicant: INSULET CORPORATION

Inventor： Jason O'CONNOR ,  Matthew ALLES ,  Robert SANZONE ,  Craig BRODEUR ,  Joseph MELO ,  Christopher WILLIAMS ,  Noel SCHAEFFER

IPC: A61M5/142

Abstract: The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal-only dosing of insulin. In a primary embodiment, the wearable drug delivery device is configured to provide automatic operation and provides audible alerts and visual status indicators to the patient. In other embodiments, the patient may have some degree of control over the operation of the device by providing tapping gestures on housing of the device. In yet another embodiment, the patient may provide input and receive status from the device via an application executing on a portable computing device in wireless communication with the wearable drug delivery device.